| Net Cash Provided by (Used in) Operating Activities |
-191M |
USD |
+52.7% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
109M |
USD |
-73% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
84.7M |
shares |
+52.1% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-82.2M |
USD |
-5071% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
152M |
USD |
+49.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
45.5M |
USD |
+232% |
Q1 2025 |
Q1 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
899K |
USD |
-22% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
2.14B |
USD |
+52% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
1.24M |
USD |
+3532% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
50.7M |
USD |
+220% |
Q1 2024 |
Q1 2024 |